(Q52745142)

6 May 2018

title

A preliminary controlled study of doxepin ("Sinequan") as an antianxiety drug (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4900938

17 March 2023

author name string

J. M. Fielding

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4900938

17 March 2023

R. M. Mowbray

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4900938

17 March 2023

B. Davies

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4900938

17 March 2023

language of work or name

English

0 references

publication date

1 October 1969

1 reference

6 May 2018

full work available at URL

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1969.tb107459.x

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107459.X

https://onlinelibrary.wiley.com/doi/full-xml/10.5694/j.1326-5377.1969.tb107459.x

17 March 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107459.X

Medical Journal of Australia

17 March 2023

published in

1 reference

6 May 2018

volume

2

1 reference

6 May 2018

issue

17

1 reference

6 May 2018

page(s)

851-852

1 reference

6 May 2018

Trial of an anti-anxiety compound-Doxepin (Sinequan)

cites work

2

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107459.X

A personality scale of manifest anxiety.

17 March 2023

4

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107459.X

17 March 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4900938

17 March 2023

1 reference

6 May 2018